Latest 8-K filings

bioAffinity Technologies announces a federal distribution agreement with AvMEDICAL to expand access to its noninvasive CyPath Lung cancer test for veterans.

PowerCompute announced the full repayment of its Bitcoin-backed loan facility, significantly reducing debt and releasing all Bitcoin collateral, while also outlining plans for increased mining hash rate.

Beacon Financial Corporation files an amendment to its Form 8-K to correct a procedural error in the original filing's item number.

Getty Images Holdings, Inc. has made overdue interest payments on its senior unsecured notes, avoiding default, but continues to face significant going concern uncertainties.

Integer Holdings Corporation announced early termination of the HSR waiting period, advancing its acquisition by KKR, expected to close by year-end 2026.

The Zcash ETF (ZCSH) announced the completion of its 3-for-1 forward share split, effective September 30, 2026, increasing outstanding shares while adjusting NAV per share.

Power Solutions International, Inc. has announced the closing of a new $220 million committed revolving credit facility, enhancing its financial flexibility and supporting future growth.

Pitney Bowes announced the repricing of its $585 million Term Loan B, reducing the interest rate margin by 75 basis points and lowering annual interest expense by approximately $4 million.

ACM Research's operating subsidiary, ACM Shanghai, announced a substantial 88.2% year-over-year increase in its total backlog as of September 29, 2026, reaching RMB 17.1 billion (USD $2.5 billion).

Celcuity Inc. announces the commercial availability of REVTORPYK (gedatolisib) in the U.S. for eligible patients with advanced breast cancer.

Electra AI, in conjunction with its business combination with Iron Horse Acquisition II Corp. (IRHO), announced new customer acquisitions and strategic partnerships, highlighting its battery intelligence platform.

Kardigan, Inc. announced the appointment of Kristin Reinke, VP of Finance at Google, to its Board of Directors and as Chair of the Audit Committee, effective September 29, 2026.

The Crypto Company announced its Frame testnet, a quantum-resistant Layer 1 blockchain, is live in private beta, processing over 7 million test transactions.

AEON Biopharma announced receipt of FDA minutes from a Type 2b meeting, which provide clarity on the development pathway for its biosimilar ABP-450, suggesting a potentially more efficient clinical development program.

Hewlett Packard Enterprise announced an increased fiscal 2027 revenue growth outlook for its Networking business and higher cost synergy targets from the Juniper Networks acquisition.

Norwegian Cruise Line Holdings Ltd. anticipates exceeding its third-quarter 2026 earnings guidance due to robust revenue performance and reaffirms its full-year 2026 outlook.

General Mills announced Dana McNabb will succeed Jeff Harmening as CEO on January 1, 2027, with Harmening transitioning to Executive Chair.

Jabil Inc. reported fourth quarter results that surpassed expectations and announced a strong fiscal year 2027 outlook, driven by significant revenue growth and expansion in key markets.

Aperture AC and Atlantic HPC Group Inc. announced the acquisition of Valley Oasis Development LLC, adding 29 MW of contracted power capacity to their digital infrastructure platform.

Conagra Brands announced its first quarter fiscal year 2027 results, reporting a slight decrease in net sales but an increase in diluted earnings per share, while reaffirming its full-year financial outlook.

Rafael Holdings announced topline data from its Phase 3 TransportNPC study for Trappsol Cyclo in Niemann-Pick Disease Type C, which did not meet its primary endpoint statistically but showed a favorable trend and significant results in a subgroup.

Winchester Bancorp, Inc. announced a new share repurchase program authorizing the buyback of up to approximately 5% of its outstanding common stock.

Professional Diversity Network, Inc. announced it has regained compliance with Nasdaq's minimum bid price requirement, closing a period of concern for investors.

Moderna announces the return of Juan Andres as Chief Operating Officer to support company expansion and diversification, alongside the retirement of Jerh Collins.

Jade Biosciences announced positive preclinical data for its anti-interferon beta monoclonal antibody, JADE301, showing potent neutralization and a favorable pharmacokinetic profile, with Phase 1 trials set to begin in Q4 2026.

The Cigna Group announced its 'Lead to One' vision at its 2026 Investor Day, emphasizing personalization at scale and complex care leadership, while reaffirming its full-year 2026 financial guidance and introducing long-term growth targets.

Johnson Controls International plc announces the departure of Julie Brandt, VP and President of Global Commercial and Field Operations, as part of an operating model transition.

ONAR Holding Corporation has completed its largest acquisition to date, purchasing Advertise Purple for up to $27.8 million, significantly expanding its revenue and technological capabilities.

Connect Biopharma announced positive topline results from its Phase 2 COPD study, showing rademikibart significantly reduced treatment failure and exacerbations.

Peoples Bancorp Inc. and Capital Bancorp, Inc. announced a definitive agreement for Peoples to acquire Capital in an all-stock transaction valued at approximately $728.1 million, creating a more diversified financial services franchise.